Search Results - "Cruz Contreras, Diego"
-
1
Real-World Overall Response Rate (ORR) of Diffuse Large B-Cell Lymphoma with Polatuzumab Vedotin-Based Theraphy, a Multicentric Study in Mexico
Published in Blood (02-11-2023)“…INTRODUCTION: Diffuse Large B-cell Lymphoma (DLBCL) is a prevalent and aggressive subtype of non-Hodgkin's lymphoma. Accurate diagnosis and timely treatment…”
Get full text
Journal Article -
2
Haploidentical Peripheral Blood Stem Cell Transplantation (Haplo-PBSCT) with Cyclophosphamide Pos Transplant (CyPost) in High-Risk Hematologic Malignancies. Results of 5 Years in Transplant Center in Northeast of Mexico
Published in Blood (23-11-2021)“…Introduction: Haploidentical peripheral blood stem cell transplantation ( Haplo-PBSCT) is a curative option in patient with hematology malignancy. In Mexico is…”
Get full text
Journal Article -
3
Can the Autologous Transplant of Hematopoyetic Progenitors be Considered an Effective Alternative to Increase Global Survival in High-Grade Non-Hodgkin Lymphomas?
Published in Blood (08-12-2017)“…Diffuse large B-cell non-Hodgkin's lymphoma (NHL) is the most common High Grade Lymphoma obtaining complete responses up to 70% with chemotherapy (R-CHOP) 1…”
Get full text
Journal Article -
4
Haploidentical Transplantation (Haplo-HSCT) with Post Transplantation Cyclophosphamide (PTCy) in Patients with High-Risk Non-Hodgkin Lymphoma and Hodgkin disease: Outcomes in Mexican Hospital-IMSS UMAE 25 Monterrey
Published in Transplantation and cellular therapy (01-02-2023)Get full text
Journal Article -
5
519 - Haploidentical Transplantation (Haplo-HSCT) with Post Transplantation Cyclophosphamide (PTCy) in Patients with High-Risk Non-Hodgkin Lymphoma and Hodgkin disease: Outcomes in Mexican Hospital-IMSS UMAE 25 Monterrey
Published in Transplantation and cellular therapy (01-02-2023)Get full text
Journal Article -
6
-
7
Poster: HL-089 Outcomes in Patients With New Diagnose of Hodgkin Disease: Real-World Data in Public Health Institution in Mexico Without Access to Anti-CD30 and PD-1 Checkpoint Inhibitors in First-Line Therapy
Published in Clinical lymphoma, myeloma and leukemia (01-10-2022)Get full text
Journal Article -
8
First Line Haploidentical Stem Cell Transplantation in Children and Adolescents with Severe Aplastic Anemia Using Mobilized Peripheral Blood As Source of CD34+ Cells
Published in Biology of blood and marrow transplantation (01-03-2020)“…The only curative treatment for severe aplastic anemia in children is allogenic stem cell transplantation, but only few patients have a matched related or…”
Get full text
Journal Article